| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948794 Enterokinetic benzamide |
| 09/07/1999 | US5948789 Process for synthesis of substituted sulphoxides |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/07/1999 | US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor |
| 09/07/1999 | US5948430 Water soluble film for oral administration with instant wettability |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | US5947708 Axial flow valve system for linear compressor |
| 09/07/1999 | CA2168563C Benzopyrans and pharmaceutical compositions containing them |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043361A1 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043339A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/02/1999 | WO1999043336A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage |
| 09/02/1999 | WO1999043310A2 20-hete antagonists and agonists |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2640994A1 Enamel matrix protein composition for preventing or treating infection |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321565A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2319123A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/01/1999 | EP0938900A1 Preventives/remedies for stomatitis |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938316A2 Galenic composition containing opioid antagonists |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938282A1 Preparation for dental treatment |
| 09/01/1999 | EP0764174B1 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227543A Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1227483A Anti-caries oral compositions |
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945415 (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for producing the same and medicinal composition containing the same |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945124 Bactericide |
| 08/31/1999 | US5945123 Determining known pharacokinetic parameters of therapeutical substance, number of doses to be administered during 24 hours and determining time at which dose will be adminstered by considering both schedule and physiological anamolies |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2007334C Anti-ulcer composition |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042465A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 08/26/1999 | WO1999042458A1 Histamine h3 receptor ligands |
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999042083A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 08/26/1999 | WO1999028342A3 Low-voltage activated calcium channel compositions and methods |
| 08/26/1999 | WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 08/26/1999 | WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/26/1999 | WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 08/26/1999 | DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction |
| 08/26/1999 | CA2321278A1 Novel compounds |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/26/1999 | CA2318836A1 Histamine h3 receptor ligands |
| 08/26/1999 | CA2263703A1 A process for producing enteric coated pancreatin granules |
| 08/25/1999 | EP0937982A2 Diagnostic and therapeutic agent for treatment of autoimmune hepatitis |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937734A1 11-Acetyl-12,13-dioxabicyclo [8.2.1] tridecenone derivatives, process for making them and pharmaceutical compositions containing them |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 08/25/1999 | EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/25/1999 | EP0937069A1 Piperazino derivatives as neurokinin antagonists |
| 08/25/1999 | EP0937065A1 Constrained somatostatin agonists and antagonists |
| 08/25/1999 | EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| 08/25/1999 | EP0937032A1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | EP0936906A1 Reflux inhibitors |
| 08/25/1999 | EP0936905A1 Immediate wettability water soluble film or water soluble layer for oral application |
| 08/25/1999 | EP0700290B1 Rectal compositions containing odansetron in its free base form |
| 08/25/1999 | EP0602211B1 Use of growth factor igf-ii for the treatment of gastrointestinal disorders |
| 08/25/1999 | CN1226899A Synthetic IL-10 analogues |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/25/1999 | CN1226886A Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 08/25/1999 | CN1226829A Method for treating gastrointestinal damage |
| 08/25/1999 | CN1226438A Composite mannosans peptides oral liquor |
| 08/25/1999 | CN1226425A Lesion-directed antibiotics in dry dosage forms for treatment of shallow ulcers of oral mucosa |
| 08/25/1999 | CN1044811C Pyrrolopyridazine derivatives |
| 08/24/1999 | US5942619 Quinoline-4-one derivatives with optional alkyl groups at positions 1 and 3, 2-substituted with a branched unsaturated alkyl optionally substituted with hydroxyl or ether; treating ulcers; biosynthesis |
| 08/24/1999 | US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |